elea
elea is an AI-native healthcare information system built for pathology laboratories and emergency departments. It orchestrates lab hardware, turns spoken clinical assessments into structured, coded reports, and hands review-ready documentation back to the physician, who keeps final medical responsibility.
What is elea?
elea is a healthcare information system built around artificial intelligence rather than bolted onto an existing one. Published by Elea.ai GmbH in Hamburg, it comes in three parts. elea Lab is presented as an AI-powered pathology operating system: it covers the full laboratory workflow, from digital order entry and sample reception through macroscopic examination and laboratory processing to histological assessment, report creation and report delivery, with billing handled inside the system in some countries. elea ED is a mobile information system for emergency departments, built for physicians and nurses alike, covering point-of-care documentation, task coordination, embedded standard operating procedures, handovers, cross-role communication and live capacity dashboards. elea DNAi is the documentation engine underneath both: a voice-driven assistant that structures a report as the clinician speaks, flags what is missing, rewrites sections on request, keeps the case context available, looks up ICD codes, applies certified CAP templates and hands the finished document over to the laboratory information system. The company states that more than 85% of cases are reviewed and approved in under 30 seconds, that its laboratories average 1.2 days from sample to report, and that its pathology AI has been trained on more than 500,000 cases. Interoperability is a stated design principle: elea connects to hospital and laboratory information systems, image management systems, scanners, cassette printers, slide printers and staining machines using HL7 and FHIR. It deliberately ships no whole-slide image viewer, connecting instead to the viewers laboratories already use, so a case opened in one system opens in the other. No special hardware is required, since the system runs in a modern browser, although many customers work primarily from a dedicated iPad app that uses the camera for scanning and the microphone for dictation. Named deployments include GastroMed Miami, OnePath Diagnostics and several German institutes, and eleaDNAi has been made available inside third-party platforms such as Techcyte Fusion and alongside Lumea's viewer. Final medical responsibility, the company states, always remains with the user.
What it does
- Turn spoken clinical assessments into structured, coded reports
- Orchestrate the pathology workflow from digital order entry to report delivery
- Extract data from paper request forms at sample reception
- Drive lab hardware such as cassette printers, slide printers and staining machines
- Document at the point of care in the emergency department by voice
- Generate handover summaries between emergency staff and inpatient teams
- Surface live queues, bottlenecks, room occupancy and waiting times
When to use elea / When not to
A quick filter to help you decide if elea is the right fit.
When to use elea
- Pathologists and heads of pathology departments who sign out high case volumes
- Medical laboratory technologists handling sample reception, grossing, staining and slide printing
- Emergency physicians and emergency nurses documenting at the point of care
- Hospital leadership and quality managers tracking turnaround times, bottlenecks and quality indicators
- Clinical documentation specialists and transcriptionists working across multi-site pathology networks
When not to use elea
- Individual clinicians and patients: elea is sold to institutions, with no self-service sign-up
- Teams that only want a dictation tool, since elea deliberately positions itself beyond transcription
- Laboratories expecting a built-in whole-slide image viewer, which elea does not ship
- Buyers who need published pricing and immediate subscription, as every deal starts with a demonstration
- Developers looking for a documented public API, as none is published
How to use elea
A typical end-to-end flow, from setup to results.
- Book a 30 to 60 minute online demonstration of elea Lab or elea ED
- Or ask for a guided free trial of elea DNAi by email, or join one of the quarterly webinars with a live demo
- Review your current processes with the elea team so the system matches your clinical reality
- Connect the existing estate: hospital and laboratory information systems, image management systems, scanners, cassette and slide printers, staining machines
- Run the role-based onboarding required for physicians, nurses and administrative staff
- In daily use, receive digital orders from referring clinics, then scan and register incoming samples
- Dictate findings during grossing and diagnosis, using voice commands to trigger printing and navigation
- Let the AI structure the report, flag what is missing and propose codes and templates
- Review, correct and sign out the report, which then flows to the LIS, to billing and to registries
- Track queues, bottlenecks and turnaround times from the live dashboards, with updates delivered automatically
Pros & Cons
Pros
- Covers the whole workflow rather than adding a module to an existing system
- Published performance figures: over 85% of cases reviewed and approved in under 30 seconds, 1.2 days on average from sample to report
- Documented interoperability with hospital and laboratory systems, image management systems, scanners and lab hardware via HL7 and FHIR
- No special hardware needed, since a modern browser is enough, with an optional dedicated iPad app
- Role-based onboarding, direct support and automatic updates delivered without downtime
- Detailed security posture: encryption in transit and at rest, role-based access, external audits and penetration testing
- Named customers and checkable press references, from German institutes to OnePath Diagnostics in the United States
Cons
- No public pricing at all: no pricing page, no tier and no currency, so every deal starts with a demonstration
- No terms and conditions are published, so ownership and reuse of clinical data cannot be checked before contracting
- The privacy policy covers only the marketing website; nothing is published on where clinical data is hosted or how long it is kept
- No subprocessor list, no customer-facing data processing agreement and no documented option to exclude data from model training
- The claim that the pathology AI is trained on more than 500,000 cases comes without any statement on where those cases came from
- No published product certification such as ISO 27001, SOC 2 or CE marking; the only certification mentioned is KV certification for German billing
- No built-in whole-slide image viewer and no documented public API, leaving imaging and integration dependent on third parties
Pricing & Plans
No pricing is published. Neither the site nor its sitemap contains a pricing page, and no amount, tier or currency appears on any of the pages reviewed. elea is sold through a 30 to 60 minute online demonstration followed by a commercial discussion, so the entry price is set per institution. A guided free trial is offered for elea DNAi on request by email, configured around the team's own reporting workflow. No permanent free plan is advertised, and the site does not state that none exists.
Data, GDPR & hosting
A consolidated view of how elea handles your data.
GDPR overview
GDPR compliance is claimed explicitly. The Security page lists compliance with all relevant data protection standards, naming GDPR and national healthcare regulations, alongside external audits and penetration testing. The FAQ adds that elea Lab is designed to meet GDPR and medical data protection requirements, with role-based access control and audit trails. The privacy policy is written under German law, cites GDPR and the TTDSG, gives a legal basis per processing operation and lists the full set of data subject rights. An external data protection officer is designated and reachable at a third-party address. Transfers outside the EU rely on standard contractual clauses and the EU-US Data Privacy Framework. No Article 27 representative is named, consistent with a controller established in Germany. That policy, however, covers the marketing website and not the clinical product.
Who owns the data?
No terms and conditions are published on the site, so data ownership can only be read from the Security page and the privacy policy. The Security page states that the customer institution retains control of its data, that data flows and processing protocols are transparent, and that there is no unauthorised data sharing. The privacy policy names Elea.ai GmbH as controller for the website, and commits to passing personal data to third parties only where a contract, a legal obligation or a legitimate interest requires it, always under a processing agreement. Ownership of the clinical data produced inside elea Lab, elea ED or DNAi is nowhere defined publicly, and would have to be settled contractually.
Reuse rights
The site publishes no terms of use, so no clause states what a customer may reuse without asking. What the pages do show is that reports stay with the institution: the clinician reviews, edits and signs out every AI-generated document before final sign-out, and elea Lab pushes billing-ready and registry-ready data back to the laboratory and to referring clinics. The privacy policy grants website visitors the GDPR right to portability in a common, machine-readable format. For clinical content, reuse rights would have to be settled in the customer contract. Nothing public restricts them, and nothing public confirms them either.
Data retention & training
Hosting summary
The only hosting statement on the site concerns the marketing website. The privacy policy names Wix (Wix.com Ltd, Tel Aviv, Israel) as the website host, adds that the data collected may sit on servers worldwide and that Wix servers are located in the USA among other places, and covers transfers outside the EU with standard contractual clauses under Article 46 GDPR and the EU-US Data Privacy Framework, also invoked for Intuit/Mailchimp, HubSpot and Google. That statement appears outdated: as of 25 August 2026 the pages are served from the Webflow CDN and the domain resolves to a Cloudflare anycast node. For the clinical product, nothing is published. The Security page promises redundant, geo-distributed environments, strict separation of environments and encryption in transit and at rest, but names no country, no region and no infrastructure provider. The publisher is established in Hamburg and operates under German law, so a European buyer should ask for the hosting jurisdiction of patient data in writing before contracting.
Things to keep in mind
Risks and trade-offs to weigh before adopting elea.
- Automation bias: when documentation arrives almost finished, the review before sign-out can quietly become a formality
- Skill erosion: clinicians who dictate freely for years may lose the habit of structuring a report themselves
- The origin of the 500,000-plus training cases is not stated, so whether patient data feeds the models is a question to put to the vendor in writing
- With no published terms, ownership and reuse of clinical data depend entirely on a contract negotiated case by case
- The hosting jurisdiction for health data is undocumented, which matters for any European buyer
- Replacing the whole information system creates deep dependence on a young vendor, with no documented exit path
- Live queue and bottleneck dashboards can drift from workflow visibility into monitoring the productivity of staff
Setup & Integrations
Technical difficulty
Two very different levels. For the end user it is close to zero: elea runs in a modern browser on standard computers, needs no special hardware, offers an optional dedicated iPad app, and most users are said to be productive after a short introduction. For the institution it is a full information system replacement, with connections to hospital and laboratory systems, image management systems, scanners and lab hardware, a joint review of existing processes, mandatory role-based onboarding and joint security assessments with IT and compliance teams. Timelines are not quantified, although the OnePath rollout was announced as a matter of weeks.
Deployment
Integrations
Behind elea
Fundraising
Social
Resources
All the official URLs gathered for verification and reference.
Frequently asked questions
Does elea Lab cover the entire pathology workflow?
Does elea require special hardware?
Can laboratory devices be connected to elea?
Can digital slides be viewed directly inside elea?
Does elea integrate with existing hospital systems?
How much does elea cost?
Is there a free trial?
Is elea GDPR compliant?
Is there a mobile application?
Who is behind elea?
Should you pick elea?
elea is one of the more complete propositions in clinical AI: not an assistant sitting next to a laboratory information system, but the system itself, rebuilt around voice and automation. The pathology workflow is covered end to end, the emergency department product addresses physicians and nurses together, and the documentation engine goes past transcription into structuring, coding and hand-off. The evidence offered is unusually concrete for a young company, with named customers on both sides of the Atlantic, partnerships with Techcyte and Lumea, published throughput figures and press coverage that can be checked. The gaps are just as clear, and they are commercial and legal rather than functional. There is no published price, no terms and conditions, and a privacy policy that stops at the marketing website. For a product that handles diagnostic data, the absence of any public statement on hosting jurisdiction, retention, subprocessors and model training is the single biggest thing to raise. The page advertising a pathology AI trained on more than 500,000 cases never says whose cases those were. None of this makes elea a poor choice; it makes it a choice to be evaluated in a room rather than from a website. Laboratories and emergency departments under staffing pressure will recognise the problems it describes, and the deployment stories suggest the team can land a replacement system without weeks of downtime. Prospective buyers should treat the demonstration as the start of a due diligence exercise, bring their IT and data protection teams, and get in writing what the public pages leave unsaid. The company is young, first archived in March 2024 and seed-funded in 2025, which is a reason for care rather than for dismissal.
- Choosing a selection results in a full page refresh.
- Opens in a new window.